Business ❯ Finance ❯ Investment ❯ Venture Capital

Series B Funding

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Investors are backing a push to prove AI-designed drugs in human trials by late 2026.

Tazapay Secures $36 Million Series B Extension Led by Circle Ventures

Bluesky Discloses $100 Million Series B, Enters Interim Leadership

Cryptio Raises $45 Million to Scale ERP-Grade Crypto Accounting for Banks

Novig Raises $75 Million at $500 Million Valuation, Seeks CFTC Path for National Sports Exchange

Naboo Raises $70 Million Series B to Build AI Tail‑Spend Procurement Platform

VelaFi Raises $20 Million to Scale Regulated Stablecoin Payments Across the Americas and Asia

RedotPay Secures $107 Million Series B to Scale Stablecoin Payments Globally

Black Forest Labs Lands $300 Million Series B at $3.25 Billion Valuation

Scribe Raises $75 Million at a $1.3 Billion Valuation to Speed Rollout of AI Workflow Optimizer

Unrivaled Expands to Eight Teams After $340 Million Valuation

Ketryx Raises $39 Million Series B to Scale AI Compliance Platform for Life Sciences

HappyRobot Raises $44 Million Series B to Scale AI Agents for Freight Operations

LayerX Raises ¥15 Billion Series B Led by TCV to Scale AI Back-Office Software

Seemplicity Raises $50 Million to Scale AI-Driven Exposure Remediation

Zama Raises $57M Series B, Achieves Unicorn Status with FHE Breakthrough